Cat. #158413
Anti-insulin-like growth factor-2 mRNA-binding protein 2 [5E10-3E1]
Cat. #: 158413
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 10-12 weeks
Target: Insulin-like growth factor 2 mRNA-binding protein 2
Class: Monoclonal
Application: WB ; IP
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Edward Chan
Institute: University of Florida Research Foundation
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-insulin-like growth factor-2 mRNA-binding protein 2 [5E10-3E1]
- Alternate name: IGF2BP2
- Research fields: Cancer;Genetics
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Reactivity: Human
- Host: Mouse
- Application: WB ; IP
- Description: IGF2BP2 is an mRNA binding protein implicated in mRNA localozation, stability, and translational control. Increased expression regulated carcinogenesis of colorectal cancer.
- Immunogen: MAb were generated using the full length recombinant human protein as antigen.
- Isotype: IgG1 kappa
Target Details
- Target: Insulin-like growth factor 2 mRNA-binding protein 2
- Target background: IGF2BP2 is an mRNA binding protein implicated in mRNA localozation, stability, and translational control. Increased expression regulated carcinogenesis of colorectal cancer.
Applications
- Application: WB ; IP
Handling
- Format: Liquid
- Unit size: 100 ug
- Shipping conditions: Dry ice
References
- Ye et al. 2016. FEBS Lett. 590(11):1641-50. PMID: 27153315.
